Article info
PDFAutoimmunity
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
- Correspondence to Dr Edward M Vital, NIHR Leeds Biomedical Research Centre, Leeds, UK; e.m.j.vital{at}leeds.ac.uk
Citation
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Publication history
- Received November 15, 2022
- Accepted February 4, 2023
- First published March 1, 2023.
Online issue publication
October 18, 2023
Article Versions
- Previous version (11 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.